Magdalena Stepaniec

Magdalena stepaniec

bookmark on deepenrich
location of Magdalena StepaniecEsplugues de Llobregat, Catalonia, Spain
Phone number of Magdalena Stepaniec+91 xxxx xxxxx
Followers of Magdalena Stepaniec610 followers
  • Timeline

    Jul 2015 - Jul 2015

    Volunteer

    University of Warsaw
    Mar 2016 - Jun 2016

    Volunteer

    Uniwersytet Warszawski
    Jul 2016 - Jul 2016

    Intern

    Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology
    Aug 2016 - Aug 2016

    Intern

    Mossakowski Medical Research Centre Polish Academy of Sciences
    Jul 2017 - Aug 2017

    Intern

    MedImmune
    Mar 2018 - Feb 2020

    Evidence Associate in Medical Evidence Hub BioPharmaceuticals Unit

    AstraZeneca
    Warsaw, Masovian District, Poland
    Mar 2020 - Apr 2021

    Project Coordinator

    Covance
    May 2021 - Apr 2023

    Global Study Manager in Study Management & Operations Oncology Unit

    AstraZeneca
    Apr 2023 - May 2024

    Senior Clinical Trial Manager delegated as Vendor Manager II to Sanofi

    ICON plc
    Current Company
    Jun 2024 - now

    Global Study Manager in Study Management & Operations Haematology Unit

    AstraZeneca
  • About me

    Global Study Manager | Haematology | CAR-T

  • Education

    • Uniwersytet warszawski

      2014 - 2017
      Bachelor of science - bsc biology, general 4

      Activities and Societies: workshops on 'Biologists' Night', workshops on Children's Day, participation in Field Biologists' Science Club. During my Bachelor's thesis I was analysing the proliferation and apoptosis in teratomas derived from Pax7+/+ and Pax7-/- murine embryonic stem cells. Results of my research are included in an article published in Cells, 2021.

    • University of warsaw

      2017 - 2019
      Master of science - msc molecular biology 5

      Activities and Societies: lectures on UniStem Days organized in 2018 and 2019, poster on 7th Intercollegiate Biotechnology Symposium 'Symbioza' in 2018, workshops on 'Biologists' Night' on 2018 In my Master's thesis I was focused on neuromuscular junctions created in vivo in muscle tissue found in murine teratomas derived from Pax7+/+ and Pax7-/- murine embryonic stem cells. Results of my research are included in an article published in Stem Cell Research & Therapy, 2020.

  • Experience

    • University of warsaw

      Jul 2015 - Jul 2015
      Volunteer

      Determining the species composition in undergrowth (hornbeam forests Tilio-Carpinetum in Białowieża, Poland) and estimating attendance using Braun-Blanquets method.

    • Uniwersytet warszawski

      Mar 2016 - Jun 2016
      Volunteer

      Obtaining cryosections of murine teratomas, basic histological stainings.

    • Maria skłodowska-curie memorial cancer centre and institute of oncology

      Jul 2016 - Jul 2016
      Intern

      Immunology: Investigating the influence of vitamin D analogues on HT29 cells preselected with 5-fluorouracil. Analysis of the expression level of selected genes in human leukocytes (RNA isolation, PCR)

    • Mossakowski medical research centre polish academy of sciences

      Aug 2016 - Aug 2016
      Intern

      Stem Cells Engineering: Obtaining and in vitro culturing of Wharton’s Jelly-derived human mesenchymal stem cells and culturing human induced pluripotent stem cells.

    • Medimmune

      Jul 2017 - Aug 2017
      Intern

      Respiratory, Inflammation & Autoimmunity: Investigating the influence of murine TSLP cytokine on murine splenocytes and murine bone marrow-derived dendritic cells. Detection and quantifying selected cytokines via ELISA assay.

    • Astrazeneca

      Mar 2018 - Feb 2020

      Studies supported: - Asthma; phase IIIb- Asthma; phase IV- Chronic Obstructive Pulmonary Disease; observational- Type 1 Diabetes Mellitus; post-authorization- ovarian cancer; phase IIIbMain responsibilities:- To work with eTMF – upload documents, pull the reports, monitor the metrics, conduct periodic Quality Checks;- To reconcile invoices of contracted vendors;- To draft study-specific plans such as TMF Plan, Sponsor Oversight Plan, Communication Plan- To support Evidence Delivery Associate Director in MHRA Inspection (Jun 2019)- To participate in Always Inspection Ready initiative;- To act as Subject Matter Expert for Sponsor Oversight Plan in primary and secondary data collection studies;- To act as Subject Matter Expert for ANGEL documentation submission;- To act as TMF Champion. Engaged in additional activities involving creating Hub-promoting presentations for occasions like EXPO 2019 in Warsaw Site, participating in Standarization and TMF Champions groups. I also participated in European Respiratory Society congress in Madrid, 2019 and in Perspektywy Women in Tech Summit in Warsaw, 2019.In 2019 I was leading my own internal 'MeetEOR' project across Evidence Associates, which aim was to become great source of knowledge for Medical Evidence people, especially for new employees. Guide was created in collaboration with about 20 people and was delivered within initially set up timelines. 'MeetEOR' is currently widely used across Medical Evidence Hub by different functions. Show less

      • Evidence Associate in Medical Evidence Hub BioPharmaceuticals Unit

        Jan 2019 - Feb 2020
      • Study Management & Operations Contractor

        Aug 2018 - Jan 2019
      • Communications Contractor

        Mar 2018 - Aug 2018
    • Covance

      Mar 2020 - Apr 2021
      Project coordinator

      Study supported:- Type 2 Diabetes Mellitus & Chronic Kidney Disease; phase IIMain responsibilities:- To manage the collaboration between LabCorp and eResearch Technology, Abbott, MediCapital Rent and Greens;- To reconcile invoices for all contracted vendors;- To manage eTMF (full responsibility);- To monitor time-billing activities.- To lead Inspection Readiness processes internally and externally;- To support start-up activities on regional level;- To oversee and mentoring senior associate, dealing with administrative matters;- To prepare, finalize and distribute meeting materials: agendas, slides, meeting minutes, ADI logs. Show less

    • Astrazeneca

      May 2021 - Apr 2023
      Global study manager in study management & operations oncology unit

      Studies supported:- Non-Small Cell Lung Cancer; phase III (3 studies, top priority in AstraZeneca Oncology portfolio)Main responsibilities:- To manage Central Laboratories and Imaging vendors (Labcorp, Invitae, Calyx, RTOG)- To manage and boost recruitment across the world;- To build up and set up processes for effective sample tracking, sample testing and site credentialing of SBRT procedures;- To oversee imaging in the study - procedures, query resolution.- To monitor and manage finances for contracted vendors: budgets and invoices;- To act as a point of contact and escalation for all laboratory-related matters in the study;- To track individually crucial samples in the study, watch the timelines and the procedures followed by the sites and laboratories;- To monitor and support sample transfers from sites to laboratories; - To train local teams from lab-related processes, sample flows and lab procedures;- To create, own and maintain lab-related documentation – Scope of Work for vendors, manuals for laboratories, logs for sites (such as HBS log);- To update study-specific documentation such as ICFs, Clinical Supplier Oversight Plan, Global Study Management Oversight Plan, TMF Plan, Vendor Communication Plan, Monitoring Plan etc.;- To report Quality Events, write/review CAPA letters, manage QEs until resolution;- To consult EC/RA country-specific lab-related submissions;- To coordinate PRF changes for ct.gov updates;- To support data cleaning in eCRFs;- To organize and lead KOM with vendors. Show less

    • Icon plc

      Apr 2023 - May 2024
      Senior clinical trial manager delegated as vendor manager ii to sanofi

      Studies supported:- Relapsing Multiple Sclerosis, phase III, 38 countries, 63 languages, 12 scales (CLS, COA, eCOA, Imaging)- Non-Relapsing Multiple Sclerosis, phase III, 25 countries, 37 languages, 12 scales (CLS, COA, eCOA, Imaging)- Asthma, phase II, 14 countries (CLS)- three Prurigo Nodularis, phases III, ~20 countries per study, ~19 lab tests per study (CLS)Main responsibilities:- COA management: establishing list of instruments, reviewing correctness of newly created scales, obtaining copyright holders details and approval to use, licensing for translational services & e-implementation - eCOA set-up: preparing RFP for vendors, reviewing proposals & contracts, establishing processes, assisting in development of e-versions of COAs, conducting UATs, managing shipments of devices- CLS set-up: preparing RFP for vendors, reviewing proposals & contracts, planning testing, shipment and monitoring activities- Imaging set-up: preparing RFP for vendors, reviewing proposals, establishing processes of data collection and reconciliationBeing a part of working group focused on establishing new, effective ways of new vendor managers' onboarding & mentoring (e.g. mentoring guide and newcomer's checklist). Show less

    • Astrazeneca

      Jun 2024 - now
      Global study manager in study management & operations haematology unit
  • Licenses & Certifications

    • Ef set spanish certificate 40/100 (a2 elementary)

      Ef set
      Feb 2025
      View certificate certificate
    • Balancing stakeholders

      Ican institute
      Dec 2022
    • Clinical trials monitoring - advanced

      Soft communication
      Nov 2020
    • Good clinical practice standard ich gcp 6

      Soft communication
      Feb 2020
    • Communicating effectively

      Ican institute
      Nov 2022